Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada

Go back to Hims & Hers Brings First-Time Access to Generic Semaglutide to Canada
(NYSE: HIMS) Delayed: 31.03 -1.67 (5.11%)
Previous Close $32.70    52 Week High
Open $33.41    52 Week Low
Day High $33.45    P/E N/A 
Day Low $30.29    EPS
Volume 10,614,355